Exicure, Inc. (XCUR) stock
XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.04−0.04 (-3.70%)
Close on Nov 18, 2026Market cap $6.81MP/E –Yield –
Exicure operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Exicure's operating income for the twelve months ending Jun 30, 2026 was -$7.34M. For fiscal 2025 it was -$4.23M. The highest annual figure on record is -$1.83M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.23M | – |
| FY2024 | Dec 31, 2024 | -$12.23M | – |
| FY2023 | Dec 31, 2023 | -$15.00M | – |
| FY2022 | Dec 31, 2022 | -$1.83M | – |
| FY2021 | Dec 31, 2021 | -$62.55M | – |
| FY2020 | Dec 31, 2020 | -$25.44M | – |
| FY2019 | Dec 31, 2019 | -$26.62M | – |
| FY2018 | Dec 31, 2018 | -$21.82M | – |
| FY2017 | Dec 31, 2017 | -$10.41M | – |
| FY2016 | Dec 31, 2016 | -$16.16M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.05M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.64M | -156.1% |
| Q4 FY2025 | Dec 31, 2025 | -$2.26M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.39M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.51M | – |
| Q1 FY2025 | Mar 31, 2025 | $2.92M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.59M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.57M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.24M | – |
| Q1 FY2024 | Mar 31, 2024 | -$836.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.50M | -108.1% |
| Q3 FY2023 | Sep 30, 2023 | -$3.32M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.64M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.54M | – |
| Q4 FY2022 | Dec 31, 2022 | $18.59M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.21M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.74M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.45M | – |
| Q3 FY2021 | Sep 30, 2021 | -$23.08M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.86M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.16M | -2376.6% |
| Q4 FY2020 | Dec 31, 2020 | -$12.46M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.12M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.39M | – |
| Q1 FY2020 | Mar 31, 2020 | $534.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.11M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.95M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.98M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.58M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.87M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.86M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.80M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.28M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.32M | – |
| Q2 FY2017 | Aug 31, 2017 | -$11.90K | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.44M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.26M | – |
See a number that looks wrong?